Trending Health

While Life Sciences organizations understand the growing potential of the global medicines market, executing successful launches in diverse markets remains a formidable challenge – requiring a balance of efficient globalized frameworks and tactics adapted to local market dynamics. In this episode, Jen is joined by Vynamic’s Global Launch Experts, Stephanie Farrell and Felice Walter, to discuss how to win when it comes to global product launch. 

Podcast Tags: healthcare, life sciences, product launch, global medicine

For more information about Vynamic’s Product Launch offerings, please visit https://vynamic.com/services/actionable-strategy/product-launch/

Source Links:

· Global Trends in R&D 2023

· The Global Use of Medicines 2022

· Deloitte’s 13th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Falls in Post-Pandemic Market

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Stephanie Farrell, Senior Director

[email protected]

Felice Walter, Senior Director

[email protected]     

Jen Burke, Director

[email protected]

On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including the significant inequalities faced by LGBTQ+ communities in the UK (0.35), a landmark mental health strategy announced by the EU Commission (7.17), and some exciting investments and developments in Neuroscience Centres of Excellence in the UK (13.17).

Podcast Tags: healthcare, healthcare news, life sciences, DEI, diversity, LGBTQ+, mental health, health equity, EU, neuroscience, scientific research, innovation, alzheimers, dementia

Source Links:  

LGBT Youth Scotland survey highlights hostile NHS healthcare | HeraldScotland 

NHS Report Reveals Significant Health And Social Inequalities Faced By Scotland’s LGBT+ Communities – News & Media (nhslothian.scot) 

LGBTQ+ staff and patients deserve better from the NHS | The King's Fund (kingsfund.org.uk) 

‘A giant step’: charities welcome plan to widen access to IVF on NHS | IVF | The Guardian 

The hidden costs facing potential LGBTQ+ parents | Stonewall 

European Commission spending €1.23bn to reform EU’s mental health - EU Reporter 

EU Commission allocates $1.3 billion to tackle mental health 'silent epidemic' | Reuters 

Antidepressants: Two million taking them for five years or more - BBC News 

Chart: Europe Is Facing a Dementia Problem | Statista 

UK on verge of new dawn for dementia treatments, says taskforce chair | Dementia | The Guardian 

UCL Neuroscience Centre of Excellence tops out | Mirage News 

Wrexham: Global drug production site gets new £75m facility - BBC News 

Medicines manufacturing has the potential to drive UK growth over the next 10 years (abpi.org.uk) 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at  

1-888-VYNAMIC.

Jen Burke, Director 

[email protected] 

Jack Young, Senior Director 

[email protected] 

Oliver May, Senior Manager  

[email protected]

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including legal challenges to the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, CMS, HHS, Medicare, drug prices

Source Links: 

• Merck sues to block Medicare negotiation of drug prices 
• Bristol Myers follows Merck's lead with its own ⁠lawsuit blasting IRA's Medicare negotiations 
• PhRMA joins legal battle over Inflation Reduction Act's 'price-setting' measures 
• Explaining the Prescription Drug Provisions in the Inflation Reduction Act 
• Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026: Moody's 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at  

1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector 

M[email protected]

Ryan Hummel, Executive and Head of Provider Sector 

[email protected]

Jen Burke, Director 

[email protected]

The role of Medical Affairs function within Life Sciences organizations continues to expand – increasing its focus on patient centricity and requiring the development of new capabilities, partnerships, and cross-functional collaboration. In this episode, Jen is joined by Vynamic’s Tamaron Bertelli and Nick Fletcher to discuss these trends and how Medical Affairs organizations can optimize their ways of working.

Podcast Tags: healthcare, life sciences, medical affairs, patient centricity, omnichannel

For more information about Vynamic’s Medical Affairs offerings, please visit https://vynamic.com/offerings/medical-affairs-2/

To learn more about the role of Medical Affairs when it comes to successful product launch, please visit https://vynamic.com/insights/six-key-elements-for-medical-affairs-in-product-launch-planning/

Source Links:

· Medical Affairs Professional Society (MAPS) Releases Vision for Future of Medical Affairs 2030

· Top 4 Medical Affairs Trends for 2023 & Beyond

· Biopharma Medical Affairs: Where We’ve Been and Where We’re Headed

· A vision for Medical Affairs in 2025

· Developing Medical Affairs Leaders Who Create the Future

· Mastering medical affairs

· The Influence Data, Digitalization & Diversity Will Have on Medical Affairs in 2023

· Medical affairs, AI and insight generation

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at

1-888-VYNAMIC.

Tamaron Bertelli, Senior Director

[email protected]

Nick Fletcher, Director

[email protected]

Jen Burke, Director

[email protected]

Regular changes to and state-to-state variations in US data privacy laws often leave the public wondering who has access to their data and how it might be used. This is especially concerning when it comes to consumer health data, where misuse of personal information could negatively impact patients’ care, treatment, and livelihood – concerns that have only been exacerbated with the overturning of Roe v. Wade. In this episode, Jen is joined by Vynamic's Jen Proietti-Fox and Courtney Ciccarelli, to discuss data privacy rules and their implications for patients, health tech companies, and the industry at large.

Podcast Tags: healthcare, healthcare technology, health tech, digital health, data privacy, women’s health, health equity

Source Links:

· The State of Consumer Data Privacy Laws in the US (And Why It Matters)

· Patient perspectives around data privacy

· State Laws Related to Digital Privacy

· U.S. Data Privacy Protection Laws: A Comprehensive Guide

· How period tracking apps and data privacy fit into a post-Roe v. Wade climate

· Period tracker Flo launches anonymous mode amid post-Roe privacy concerns

· These Period Tracker Apps Say They Put Privacy First. Here’s What We Found.

· SXSW 2023: Data privacy, healthcare websites new battlegrounds over reproductive rights

· ‘Shut it off immediately’: The health industry responds to data privacy crackdown

· Examining the intersection of data privacy and civil rights

· ACLU OF FLORIDA STATEMENT ON BILL THAT ALLOWS HEALTHCARE PROVIDERS AND PAYORS TO REFUSE HEALTHCARE TO FLORIDIANS

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Jen Proietti-Fox, Director

[email protected]

Courtney Ciccarelli, Director

[email protected]

Jen Burke, Director

[email protected]

On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including an update on the UK’s Life Sciences Plan, pharmaceutical industry growth in Denmark and Sweden, and UK funding for extended reality mental health projects.

Podcast Tags: healthcare, healthcare news, biopharma, life sciences, UK, Denmark, Sweden, public health, mental health, virtual reality, augmented reality, extended reality

Source Links:

· Bold new life sciences vision sets path for UK to build on pandemic response and deliver life-changing innovations to patients

· Delivery pivotal as UK life sciences plan takes shape

· Happy pills: How Sweden and Denmark became rare bright spots for Europe’s pharma industry

· Leading countries by research and development (R&D) expenditure as share of gross domestic product (GDP) worldwide in 2022

· AstraZeneca chair Johansson to retire in 2023 after 11 years in role

· Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW)

· Novo Nordisk Foundation Quantum Computing Programme

· UK funds extended reality projects for mental health

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Jack Young, Senior Director

[email protected]

Oliver May, Senior Manager 

[email protected]

Jen Burke, Director

[email protected]

In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including recent approvals from the House Energy and Commerce Subcommittee on Health and Phase 3 clinical trial results for oral semaglutide to treat obesity.

Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, Medicare, drug prices, PBMs, 340B, obesity

Source Links: 

• A key House panel approved a slew of health policies. Here's a look at 4 of them 
• Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial 
• Anti-obesity medications are set to skyrocket this year. But how will we afford them? 
• What Could New Anti-Obesity Drugs Mean for Medicare? 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector 

[email protected]

Ryan Hummel, Executive and Head of Provider Sector 

[email protected]

Jen Burke, Healthcare Industry Strategist 

[email protected]

The emerging need for connected, digital patient healthcare solutions has been accelerated by the healthcare workforce crisis – and improved options for scalable patient monitoring and data analytics have provided opportunities for the MedTech industry to jump in. In this episode, Jen is joined by Vynamic Director Andrew Sgarlato and Executive and Head of Healthcare Technology, Mary Virzi, to discuss what MedTech organizations should be thinking about as they invest in the burgeoning digital health space.

Podcast Tags: healthcare, healthcare technology, health tech, med tech, medical devices, digital health, remote patient monitoring, big data, machine learning, artificial intelligence

Source Links:

· What Medtech Startups Need to know About Remote Monitoring

· A Knee Replacement that talks to your Doctor? It’s just the beginning.

· When does a digital health project become a medical device

· How the right infrastructure increases the resilience of your HealthTech devices

· Friday Q&A: For GE HealthCare, the future is digital, CEO Arduini says

· How the medtech industry can capture value from digital health

· Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

· Medtech buyouts by private equity in Q4 shed light on deal-making trends in 2023: report

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mary Virzi, Executive and Head of Healthcare Technology

[email protected]

Andrew Sgarlato, Director

[email protected]

Jen Burke, Healthcare Industry Strategist

[email protected]

On this week’s Trending News EU episode, Jack, Gemma, and Adrien share their insights from the recent Reuters Pharma 2023 conference held in Barcelona including the latest developments on Digital Health (1.51), Medical Affairs (3.50), Patient Engagement (7.11), and the perspectives from pharma leaders who attended Vynamic’s roundtable on patient initiative impact measurement (10.06)

Podcast Tags: healthcare, pharma, digital health, medical affairs, patient engagement, omnichannel patient experience, metrics, impact

Source Links:  

Pharma 2023 (reutersevents.com)

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at  

1-888-VYNAMIC.

Jen Burke, Healthcare Industry Strategist

[email protected]

Jack Young, Senior Director

[email protected]

Gemma Pfister, Senior Executive

[email protected]

Adrien Moucquot, Senior Director

[email protected]

In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including the judicial activity surrounding Mifepristone, a medical abortion drug, and the recent announcement of Kaiser’s acquisition of Geisinger to launch Risant Health.  

Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, mergers and acquisitions, FDA 

Source Links: 

• Texas judge halts FDA approval of abortion pill 
• Supreme Court preserves access to key abortion drug as appeal proceeds   
• Supreme Court Delays Decision on Abortion Pill, Preserving Access for Now   
• Generic abortion pill manufacturer sues FDA in effort to preserve access   
• Supreme Court Ensures, for Now, Broad Access to Abortion Pill   
• 6 Ways the Mifepristone Rulings May Impact Future FDA Approvals  
• Kaiser Permanente to Acquire Geisinger   
• Kaiser Permanente and Geisinger come together to launch Risant Health  
• Kaiser Permanente: Commitments and Impact 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector 

[email protected] 

Ryan Hummel, Executive and Head of Provider Sector 

[email protected] 

Jen Burke, Healthcare Industry Strategist 

[email protected]